CN102395563A - 联苯-2-基氨基甲酸酯的制备方法 - Google Patents
联苯-2-基氨基甲酸酯的制备方法 Download PDFInfo
- Publication number
- CN102395563A CN102395563A CN2010800169058A CN201080016905A CN102395563A CN 102395563 A CN102395563 A CN 102395563A CN 2010800169058 A CN2010800169058 A CN 2010800169058A CN 201080016905 A CN201080016905 A CN 201080016905A CN 102395563 A CN102395563 A CN 102395563A
- Authority
- CN
- China
- Prior art keywords
- compound
- formula
- solvent
- chloro
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 COC1=CC(N[N+](C=C)[O-])=C(*)CC1=C=O Chemical compound COC1=CC(N[N+](C=C)[O-])=C(*)CC1=C=O 0.000 description 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/30—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
- C07C233/33—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
Claims (13)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16904609P | 2009-04-14 | 2009-04-14 | |
US61/169046 | 2009-04-14 | ||
PCT/EP2010/054893 WO2010119064A1 (en) | 2009-04-14 | 2010-04-14 | Process for the preparation of a biphenyl-2-ylcarbamic acid ester |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102395563A true CN102395563A (zh) | 2012-03-28 |
CN102395563B CN102395563B (zh) | 2015-05-20 |
Family
ID=42224367
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201080016905.8A Active CN102395563B (zh) | 2009-04-14 | 2010-04-14 | 联苯-2-基氨基甲酸酯的制备方法 |
Country Status (15)
Country | Link |
---|---|
US (1) | US8519138B2 (zh) |
EP (1) | EP2419409B1 (zh) |
JP (2) | JP5540075B2 (zh) |
KR (1) | KR101720154B1 (zh) |
CN (1) | CN102395563B (zh) |
AU (1) | AU2010238504B2 (zh) |
BR (1) | BRPI1013562B1 (zh) |
CA (1) | CA2758353C (zh) |
EA (1) | EA022030B1 (zh) |
ES (1) | ES2535326T3 (zh) |
IL (1) | IL215550A (zh) |
MX (1) | MX2011010934A (zh) |
SG (1) | SG175023A1 (zh) |
WO (1) | WO2010119064A1 (zh) |
ZA (1) | ZA201107378B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106632257A (zh) * | 2016-12-15 | 2017-05-10 | 上海市奉贤区中心医院 | Gsk961081及其中间体的合成方法 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT107101A (pt) | 2013-08-02 | 2015-02-02 | Univ De Coimbra | Painéis flexíveis de aerogel hidrofóbico reforçado com feltro de fibras |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4179507A (en) * | 1975-12-10 | 1979-12-18 | Burroughs Wellcome Co. | Quarternary ammonium compounds |
CN101239971A (zh) * | 2003-02-14 | 2008-08-13 | 施万制药 | 联苯衍生物 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20040950A1 (es) | 2003-02-14 | 2005-01-01 | Theravance Inc | DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS |
US7317102B2 (en) * | 2003-04-01 | 2008-01-08 | Theravance, Inc. | Diarylmethyl and related compounds |
CN100569760C (zh) * | 2003-11-21 | 2009-12-16 | 施万制药 | 具有β2肾上腺素能受体激动剂和毒蕈碱性受体拮抗剂活性的化合物 |
TWI374883B (en) * | 2004-08-16 | 2012-10-21 | Theravance Inc | Crystalline form of a biphenyl compound |
WO2006023460A2 (en) * | 2004-08-16 | 2006-03-02 | Theravance, Inc. | COMPOUNDS HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY |
WO2006138218A1 (en) * | 2005-06-13 | 2006-12-28 | Theravance, Inc. | Biphenyl compounds useful as muscarinic receptor antagonists |
GB0602778D0 (en) * | 2006-02-10 | 2006-03-22 | Glaxo Group Ltd | Novel compound |
TW200811104A (en) * | 2006-04-25 | 2008-03-01 | Theravance Inc | Crystalline forms of a dimethylphenyl compound |
-
2010
- 2010-04-14 BR BRPI1013562-6A patent/BRPI1013562B1/pt active IP Right Grant
- 2010-04-14 US US13/263,857 patent/US8519138B2/en active Active
- 2010-04-14 EP EP10713940.4A patent/EP2419409B1/en active Active
- 2010-04-14 KR KR1020117026946A patent/KR101720154B1/ko active IP Right Grant
- 2010-04-14 MX MX2011010934A patent/MX2011010934A/es active IP Right Grant
- 2010-04-14 AU AU2010238504A patent/AU2010238504B2/en active Active
- 2010-04-14 EA EA201190203A patent/EA022030B1/ru not_active IP Right Cessation
- 2010-04-14 CA CA2758353A patent/CA2758353C/en active Active
- 2010-04-14 WO PCT/EP2010/054893 patent/WO2010119064A1/en active Application Filing
- 2010-04-14 ES ES10713940.4T patent/ES2535326T3/es active Active
- 2010-04-14 CN CN201080016905.8A patent/CN102395563B/zh active Active
- 2010-04-14 SG SG2011071719A patent/SG175023A1/en unknown
- 2010-04-14 JP JP2012505154A patent/JP5540075B2/ja active Active
-
2011
- 2011-10-05 IL IL215550A patent/IL215550A/en active IP Right Grant
- 2011-10-07 ZA ZA2011/07378A patent/ZA201107378B/en unknown
-
2014
- 2014-05-01 JP JP2014094409A patent/JP5714748B2/ja active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4179507A (en) * | 1975-12-10 | 1979-12-18 | Burroughs Wellcome Co. | Quarternary ammonium compounds |
CN101239971A (zh) * | 2003-02-14 | 2008-08-13 | 施万制药 | 联苯衍生物 |
Non-Patent Citations (1)
Title |
---|
NIRMAL C. DHAR,等: "Approaches to Short-Acting Neuromuscular Blocking Agents:Nonsymmetrical Bis-tetrahydroisoquinolinium Mono- and Diesters", 《JOURNAL OF MEDICINAL CHEMISTRY》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106632257A (zh) * | 2016-12-15 | 2017-05-10 | 上海市奉贤区中心医院 | Gsk961081及其中间体的合成方法 |
CN106632257B (zh) * | 2016-12-15 | 2019-02-12 | 上海市奉贤区中心医院 | Gsk961081及其中间体的合成方法 |
Also Published As
Publication number | Publication date |
---|---|
AU2010238504A1 (en) | 2011-11-03 |
EA201190203A1 (ru) | 2012-05-30 |
ES2535326T3 (es) | 2015-05-08 |
JP2012523447A (ja) | 2012-10-04 |
BRPI1013562A2 (pt) | 2020-08-18 |
JP5540075B2 (ja) | 2014-07-02 |
JP5714748B2 (ja) | 2015-05-07 |
US8519138B2 (en) | 2013-08-27 |
US20120046469A1 (en) | 2012-02-23 |
WO2010119064A1 (en) | 2010-10-21 |
KR20120006054A (ko) | 2012-01-17 |
BRPI1013562B1 (pt) | 2021-08-03 |
KR101720154B1 (ko) | 2017-03-27 |
EP2419409A1 (en) | 2012-02-22 |
EA022030B1 (ru) | 2015-10-30 |
IL215550A0 (en) | 2011-12-29 |
CA2758353A1 (en) | 2010-10-21 |
CN102395563B (zh) | 2015-05-20 |
JP2014193873A (ja) | 2014-10-09 |
MX2011010934A (es) | 2011-11-02 |
ZA201107378B (en) | 2013-03-27 |
AU2010238504B2 (en) | 2015-04-16 |
SG175023A1 (en) | 2011-11-28 |
IL215550A (en) | 2016-03-31 |
CA2758353C (en) | 2017-06-06 |
EP2419409B1 (en) | 2015-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI250974B (en) | Methods for preparing CETP inhibitors | |
WO2017096772A1 (zh) | 一种抗心衰药lcz696的制备方法 | |
CN102336705A (zh) | 一种制备n-(3,5-二氯吡啶-4-基)-3-环丙基甲氧基-4-二氟甲氧基苯甲酰胺的方法 | |
CN102395563A (zh) | 联苯-2-基氨基甲酸酯的制备方法 | |
TWI591045B (zh) | 作為有效藥劑成分之6-胺基己酸的製造方法 | |
EP4126821B1 (en) | Process for the preparation of (r)-4-(1-(6-(4-(trifluoromethyl)benzyl)-6-azaspiro[2.5]octane-5-carboxamido)-cyclopropyl) benzoic acid or a salt thereof | |
JP2005514459A (ja) | フェンセリン及びその類似体を生成するための方法 | |
CN106631831A (zh) | 一种左旋特布他林的制备方法 | |
JP6137185B2 (ja) | (r)−1,1,3−トリメチル−4−アミノインダンの製造方法 | |
CN101910124B (zh) | 光学活性3-氨基吡咯烷盐、其制造方法以及3-氨基吡咯烷的光学拆分方法 | |
CN1742004A (zh) | 具有止痛活性的吲唑酰胺类 | |
JP2002532494A (ja) | パロキセチンの誘導体 | |
CN112094219B (zh) | 一种制备钾离子竞争性阻滞剂中间体的方法 | |
CN103333103B (zh) | 一锅法制备马来酸氟吡汀的方法 | |
CN112174798B (zh) | 一种沙库巴曲缬沙坦钠lcz696的合成方法 | |
CN109810052B (zh) | 一种高选择性的阿帕替尼的简便制备方法 | |
EP1881956A1 (de) | 3-(2-(dimethylamino)methyl-(cyclohex-1-yl))phenol-maleat und dessen kristalline formen | |
CN105712920B (zh) | 一种维格列汀的制备方法 | |
RU2741389C1 (ru) | Способ получения промежуточного соединения для синтеза лекарственного средства | |
CN1318054A (zh) | 新化合物 | |
JP2812761B2 (ja) | クロロマレエートまたはクロロフマレートまたはそれらの混合物を経るアニリノフマレートの製造方法 | |
CN115611749A (zh) | 一种酒石酸左沙丁胺醇的制备方法 | |
TWI753978B (zh) | 製備4-胺基-3-氯-5-氟-6-(4-氯-2-氟-3-甲氧基苯基)吡啶甲酸甲酯之方法 | |
JPWO2016171240A1 (ja) | ジカルボン酸化合物の製法 | |
JP4014138B2 (ja) | 製造中間体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210408 Address after: California, USA Patentee after: THERAVANCE BIOPHARMA R&D IP, LLC Address before: The Middlesex County Patentee before: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT Ltd. Effective date of registration: 20210408 Address after: The Middlesex County Patentee after: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT Ltd. Address before: British Ahmed Sykes Patentee before: GLAXO Group Ltd. |
|
TR01 | Transfer of patent right |